Evidence map›Paper›PMID 23163834›Full record

ArticleJournal of proteome research2013

Metabolomics of cerebrospinal fluid from humans treated for rabies.

Aifric O'Sullivan, Rodney E Willoughby, Darya Mishchuk, Brisa Alcarraz, Cesar Cabezas-Sanchez, Rene Edgar Condori, Dan David, Rafael Encarnacion, Naaz Fatteh, Josefina Fernandez and 8 more

Abstract read
In one paragraph

Article in Journal of proteome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. NMR-based metabolomics of human cerebrospinal fluid identifies signature of brain death.Metabolomics : Official journal of the Metabolomic Society · 2021
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Perspectives in Diagnosis and Treatment of Rabies Viral Encephalitis: Insights from Pathogenesis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2016
    Review
  17. Article
  18. Virology, immunology and pathology of human rabies during treatment.The Pediatric infectious disease journal · 2015
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Aifric O'SullivanDepartment of Food Science and Technology, University of California, Davis, California 95616, United States.
Rodney E Willoughby
Darya Mishchuk
Brisa Alcarraz
Cesar Cabezas-Sanchez
Rene Edgar Condori
Dan David
Rafael Encarnacion
Naaz Fatteh
Josefina Fernandez
Richard Franka
Sara Hedderwick
Conall McCaughey
Joanne Ondrush
Andres Paez-Martinez
Charles Rupprecht
Andres Velasco-Villa
Carolyn M Slupsky
Centers for Disease Control and Prevention · USHospital Infantil Dr. Robert Reid Cabral · DOInova Fairfax Hospital · USInstituto Nacional de Salud · PEHospital Nacional Cayetano Heredia · PEInstituto Nacional de Salud · COMedical College of Wisconsin · USMinistry of Agriculture and Rural Development · ILUniversity of California, Davis · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Rabies is a rapidly progressive lyssavirus encephalitis that is statistically 100% fatal. There are no clinically effective antiviral drugs for rabies. An immunologically naïve teenager survived rabies in 2004 through improvised supportive care; since then, 5 additional survivors have been associated with use of the so-called Milwaukee Protocol (MP). The MP applies critical care focused on the altered metabolic and physiologic states associated with rabies. The aim of this study was to examine the metabolic profile of cerebrospinal fluid (CSF) from rabies patients during clinical progression of rabies encephalitis in survivors and nonsurvivors and to compare these samples with control CSF samples. Unsupervised clustering algorithms distinguished three stages of rabies disease and identified several metabolites that differentiated rabies survivors from those who subsequently died, in particular, metabolites related to energy metabolism and cell volume control. Moreover, for those patients who survived, the trajectory of their metabolic profile tracked toward the control profile and away from the rabies profile. NMR metabolomics of human rabies CSF provide new insights into the mechanisms of rabies pathogenesis, which may guide future therapy of this disease.

Indexed as

MetabolomicsRabiesRabies virusAdolescentAdultAntiviral AgentsFemaleGene Expression ProfilingHumansMaleRabies VaccinesAntiviral AgentsRabies Vaccines

Identifiers

PMID23163834
PMCPMC4824192
OpenAlexW2045321229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.